Skip to main content

Actions of benzophenanthridine alkaloids and various synthetic compounds on the cannabinoid-1 (CB1) receptor pathway of mouse brain with particular reference to the effects on [3H]CP55940 and [3H]SR141716A binding, interference with basal and CP55940-stim

Resource type
Thesis type
(Thesis) Ph.D.
Date created
2012-08-15
Authors/Contributors
Abstract
Benzophenanthridine alkaloids chelerythrine and sanguinarine inhibited the binding of 3HCP55940 and 3HSR141716A to mouse brain membranes IC50s approx. 1-2 µM. Piperonyl butoxide and S-methoprene were more potent inhibitors of 3HCP55940 binding IC50s: 8.2µM and 16.4µM respectively than of 3HSR141716A binding IC50s: 21µM and 63µM respectively. Binding experiments demonstrated selectivity towards brain CB1 versus spleen CB2 receptor. Benzophenanthridines reduced Kd of 3HCP55940 binding to brain membranes whereas S-methoprene and piperonyl butoxide lowered Bmax. These study compounds reduced association of 3HCP55940 and 3HSR141716A, benzophenanthridines were consistently more effective. In presence of a saturating concentration of SR141716A, S-methoprene and piperonyl butoxide increased dissociation of 3HSR141716A above that observed with SR141716A alone. All compounds activated 3HSR141716A dissociation when assayed alone, but S-methoprene was the least effective. In separate studies, phthalate diesters reduced the Bmax of 3HSR141716A without affecting Kd, increased 3HSR141716A dissociation above saturating concentration of AM251. Benzophenanthridines antagonized CP55940-stimulated and basal binding of 35SGTPyS to the G-protein of mouse brain, whereas piperonyl butoxide and S-methoprene inhibited CP55940-stimulated 35SGTPyS binding only. Inhibition of CP55940-stimulated binding of 35SGTPyS was also demonstrated with phthalates. 4-Aminopyridine-4-AP-induced release of L-glutamate from mouse brain synaptosomes was partially inhibited by WIN55212-2. The inhibitory effect of WIN55212-2 was completely neutralized by AM251, S-methoprene, piperonyl butoxide and phthalate diesters, whereas in the presence of WIN55212-2, the benzophenanthridines enhanced 4-AP-induced L-glutamate release above caused by 4-AP alone. The 3HCP55940 and 3HSR141716A binding data suggest that study compounds modify radioligand binding allosterically. The 35SGTPyS binding results suggest that chelerythrine and sanguinarine are inverse agonists of G-protein-coupled CB1 receptors, piperonyl butoxide, S-methoprene and phthalate diesters are neutral lower potency antagonists. Modulation 4-AP-evoked L-glutamate release from synaptosomes by the study compounds with WIN-55212-2 present strongly supports this latter profiling. Although these compounds exhibit lower potencies versus many conventional CB1 receptor inhibitors, further studies are warranted, given their potential to 1 modify CB1 receptor-dependent behavioral/physiological outcomes in the whole animal, and 2 serve as starting structures for synthesis of novel/more potent G-protein-coupled CB1 receptor blocking drugs.
Document
Identifier
etd7361
Copyright statement
Copyright is held by the author.
Permissions
The author granted permission for the file to be printed and for the text to be copied and pasted.
Scholarly level
Supervisor or Senior Supervisor
Thesis advisor: Nicholson, Russell
Member of collection
Download file Size
etd7361_ADhopeshwarkar.pdf 8.3 MB

Views & downloads - as of June 2023

Views: 9
Downloads: 0